Tenke, P., Köves, B. & Johansen, T. E. B. (2014). An update on prevention and treatment of catheter-associated urinary tract infections. Current Opinion in Infectious Diseases, 27(1), 102-7. https://doi.org/10.1097/QCO.0000000000000031

Doizi, S., Knoll, T., Scoffone, C. M., Breda, A., Brehmer, M., Liatsikos, E., Cornu, J.-N. & Traxer, O. (2014). First clinical evaluation of a new innovative ureteral access sheath (Re-Trace™): a European study. World Journal of Urology, 32(1), 143-7. https://doi.org/10.1007/s00345-013-1094-3

Kingo, P. S., Høyer, S., Marinovskij, E. & Rawashdeh, Y. F. (2014). Paediatric urachal benign teratoma: a case report and review of the literature. Acta Pathologica et Microbiologica Scandinavica APMIS. https://doi.org/10.1111/apm.12216

Olsen, L. H. (2014). A two way reciprocal solution. NUF-bulletin, 1(1/2014), 15-17.

Cek, M., Tandoğdu, Z., Wagenlehner, F., Tenke, P., Naber, K. & Johansen, T. E. B. (2014). Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010. World Journal of Urology, 32(6), 1587-1594. https://doi.org/10.1007/s00345-013-1218-9

Kingo, P. S. & Ryhammer, A. M. (2014). Akut urinretention hos yngre kvinde med Lyme borreliose. Ugeskrift for Læger.

Jensen, B. T., Petersen, A. K., Jensen, J. B., Laustsen, S. & Borre, M. (2014). Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: A prospective randomized controlled trial. Scandinavian Journal of Urology and Nephrology, 49(2), 133-141. https://doi.org/10.3109/21681805.2014.967810

Laurberg, J. R., Jensen, J. B., Schepeler, T., Borre, M., Ørntoft, T. F. & Dyrskjøt, L. (2014). High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer. B M C Cancer, 14, Article 14. https://doi.org/10.1186/1471-2407-14-638

Mortensen, M. M., Høyer, S., Orntoft, T. F., Sørensen, K. D., Dyrskjøt, L. & Borre, M. (2014). High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy. B M C Cancer, 14, 859. https://doi.org/10.1186/1471-2407-14-859

Jensen, B. T., Jensen, J. B., Laustsen, S., Petersen, A. K., Søndergaard, I. & Borre, M. (2014). Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial. Journal of Multidisciplinary Healthcare, 7, 301-11. https://doi.org/10.2147/JMDH.S62172

Haldrup, C., Kosaka, N., Ochiya, T., Borre, M., Høyer, S., Ørntoft, T. F. & Sørensen, K. D. (2014). Profiling of circulating microRNAs for prostate cancer biomarker discovery. Drug Delivery and Translational Research, 4(1), 19-30. https://doi.org/10.1007/s13346-013-0169-4

Drljevic, A., Borre, M., Høyer, M., Ehrenstein, V. & Nguyen-Nielsen, M. (2014). Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients. Clinical epidemiology, 6, 351-7. https://doi.org/10.2147/CLEP.S65681

van Rijt, W. G., Secher, N., Keller, A. K., Møldrup, U., Chynau, Y., Ploeg, R. J., van Goor, H., Nørregaard, R., Birn, H., Frøkiaer, J., Nielsen, S., Leuvenink, H. G. D. & Jespersen, B. (2014). α-Melanocyte Stimulating Hormone Treatment in Pigs Does Not Improve Early Graft Function in Kidney Transplants from Brain Dead Donors. PLOS ONE, 9(4), e94609. https://doi.org/10.1371/journal.pone.0094609

Sanguedolce, F., Breda, A., Millan, F., Brehmer, M., Knoll, T., Liatsikos, E., Osther, P., Traxer, O. & Scoffone, C. (2013). Lower pole stones: prone PCNL versus supine PCNL in the International Cooperation in Endourology (ICE) group experience. World Journal of Urology, 31(6), 1575-80. https://doi.org/10.1007/s00345-012-0941-y

Elkjær, M. C. & Borre, M. (2013). Only carefully selected patients may have a beneficial effect of salvage cryoablation in recurrent prostate cancer after radiotherapy. Danish Medical Journal, 60(12), A4756.

Thomsen, F. B., Røder, M. A., Rathenborg, P., Brasso, K., Borre, M. & Iversen, P. (2013). Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate. Scandinavian Journal of Urology and Nephrology. https://doi.org/10.3109/21681805.2013.860189

Fode, M., Borre, M., Ohl, D. A., Lichtbach, J. & Sønksen, J. O. R. (2013). Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. B J U International (Print). https://doi.org/10.1111/bju.12501

Cockle-Hearne, J., Charnay-Sonnek, F., Denis, L., Fairbanks, H. E., Kelly, D., Kav, S., Leonard, K., van Muilekom, E., Fernandez-Ortega, P., Jensen, B. T. & Faithfull, S. (2013). The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries. B J C, 109(8), 2121-30. https://doi.org/10.1038/bjc.2013.568

Cronin-Fenton, D. P., Antonsen, S., Cetin, K., Daniels, A., Borre, M., Acquavella, J. & Lash, T. L. (2013). Mortality and incidence of new primary cancers in men with prostate cancer: a Danish population-based cohort study. Cancer epidemiology, 37(5), 562-8. https://doi.org/10.1016/j.canep.2013.06.002

Jespersen, C. G., Nørgaard, M., Friis, S., Skriver, C. & Borre, M. (2013). Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997-2010. Cancer epidemiology, 38(1), 42-7. https://doi.org/10.1016/j.canep.2013.10.010

Haldrup, C., Mundbjerg, K., Vestergaard, E. M., Lamy, P., Wild, P., Schulz, W. A., Arsov, C., Visakorpi, T., Borre, M., Høyer, S., Orntoft, T. F. & Sørensen, K. D. (2013). DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer. Journal of Clinical Oncology, 31(26), 3250-8. https://doi.org/10.1200/JCO.2012.47.1847

Wagenlehner, F. M. E., Bartoletti, R., Cek, M., Grabe, M., Kahlmeter, G., Pickard, R. & Johansen, T. E. B. (2013). Antibiotic stewardship: a call for action by the urologic community. European Urology, 64(3), 358-60. https://doi.org/10.1016/j.eururo.2013.05.044

Jensen, B. T., Laustsen, S., Petersen, A. K., Borre, M., Soendergaard, I., Jensen, K. M.-E., Lash, T. L. & Borre, M. (2013). Preoperative risk factors related to bladder cancer rehabilitation: a registry study. European Journal of Clinical Nutrition, 67(9), 917-21. https://doi.org/10.1038/ejcn.2013.120

Munk, M., Memon, A., Poulsen, S. S., Borre, M., Nexo, E. & Sorensen, B. S. (2013). The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed. Scandinavian journal of clinical and laboratory investigation, 73(6), 503-13. https://doi.org/10.3109/00365513.2013.818706

Røder, M. A., Brasso, K., Christensen, I. J., Johansen, J., Langkilde, N. C., Hvarness, H., Carlsson, P. S., Jakobsen, H., Borre, M. & Iversen, P. (2013). Changes in preoperative characteristics in patients undergoing radical prostatectomy - a 16-year nationwide analysis. Acta Oncologica. https://doi.org/10.3109/0284186X.2013.819998

Johansen, T. E. B. (2013). Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. B J U International (Print), 112(4), E262-4. https://doi.org/10.1111/j.1464-410X.2012.11784.x

Lund, L., Jønler, M., Graversen, P. H., Borre, M. & Bro, F. (2013). Shared care is a model for patients with stable prostate cancer. Danish Medical Journal, 60(8), A4691.

Mortensen, G. L. & Jakobsen, J. K. (2013). Patient perspectives on quality of life after penile cancer. Danish Medical Journal, 60(7), A4655.

Borre, M. (2013). Nye MR-skanningsteknikker ved prostatacancer--tæt på og lige ved. Ugeskrift for Læger, 175(23), 1629.

Hansen, E. L., Hvistendahl, G. M., Rawashdeh, Y. F. H. & Olsen, L. H. (2013). Promising long-term outcome of bladder auto-augmentation in children with neurogenic bladder dysfunction. Journal of Urology. https://doi.org/10.1016/j.juro.2013.05.035

Elkjær, M. C. & Borre, M. (2013). Oncological outcome after primary prostate cryoablation compared with radical prostatectomy: A single-centre experience. Scandinavian Journal of Urology and Nephrology.

Jespersen, C. G., Nørgaard, M. & Borre, M. (2013). Reply to C. Mary Schooling, Grace Sembajwe, and Ilir Agaliu's Letter to the Editor re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002. European Urology (Italian Edition), 64(3), e61. https://doi.org/10.1016/j.eururo.2013.04.016

Keller, A. K., Lassen, C. K., Møldrup, U., Bibby, B. M. & Jespersen, B. (2013). Messengers of renal graft quality during warm and cold ischemia - a porcine microdialysis study. Transplantation Proceedings, 45(3), 1172-7.

Røder, M. A., Brasso, K., Christensen, I. J., Johansen, J., Langkilde, N. C., Hvarness, H., Carlsson, S., Jakobsen, H., Borre, M. & Iversen, P. (2013). Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study. B J U International (Print). https://doi.org/10.1111/bju.12065

Christensen, J. S., Asklund, C., Skakkebæk, N. E., Jørgensen, N., Andersen, H. R., Jørgensen, T. M., Olsen, L. H., Høyer, A. P., Moesgaard, J., Thorup, J. M. & Jensen, T. K. (2013). Association between organic dietary choice during pregnancy and hypospadias in offspring: A study of mothers of 306 boys operated for hypospadias. The Journal of Urology, 189(3), 1077-1082. https://doi.org/10.1016/j.juro.2012.09.116

Wagenlehner, F. M. E., van Oostrum, E., Tenke, P., Tandogdu, Z., Çek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W., Johansen, T. E. B. & GPIU investigators (2013). Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. European Urology, 63(3), 521-7. https://doi.org/10.1016/j.eururo.2012.06.003

Wagenlehner, F., van Oostrum, E., Tenke, P., Tandogdu, Z., Cek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W. & Johansen, T. E. B. (2013). Reply from Authors re.: Riccardo Bartoletti, Tommaso Cai.Prostate Biopsies Should Be Performed According to a Standard of Care. European Urology, 63(3), 529-30. Article 63, 3. https://doi.org/10.1016/j.eururo.2012.07.037

Jespersen, C. G., Nørgaard, M. & Borre, M. (2013). Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. European Urology (Italian Edition). https://doi.org/10.1016/j.eururo.2013.02.002

Fristrup, N., Birkenkamp-Demtröder, K., Reinert, T., Sanchez-Carbayo, M., Segersten, U., Malmström, P.-U., Palou, J., Alvarez-Múgica, M., Pan, C.-C., Ulhøi, B. P., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2013). Multicenter validation of Cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle invasive bladder cancer. American Journal of Pathology, 182(2), 339-349. https://doi.org/10.1016/j.ajpath.2012.10.017

Sørensen, K. D., Abildgaard, M. O., Haldrup, C., Ulhøi, B. P., Kristensen, H., Strand, S. H., Parker, C., Høyer, S., Borre, M. & Ørntoft, T. F. (2013). Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer. B J C, (108), 420-428. https://doi.org/10.1038/bjc.2012.549

Birkenkamp-Demtröder, K., Mansilla, F., Andersen, L. D., Thorsen, K., Fristrup, N., Brems-Eskildsen, A. S., Madsen, P. P., Sørensen, K. D., Borre, M. & Ørntoft, T. F. (2013). TOX3 (TNRC9) overexpression in bladder cancer cells decreases cellular proliferation and triggers an interferon-like response. Journal of Molecular Biomarkers & Diagnosis, 4(1), 1-11. https://doi.org/10.4172/2155-9929.1000140

Schepeler, T., Lamy, P., Hvidberg, V., Laurberg, J. R., Fristrup, N., Reinert, T., Bartkova, J., Tropia, L., Bartek, J., Halazonetis, T. D., Pan, C.-C., Borre, M., Andersen, L. D. & Orntoft, T. F. (2013). A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response. Oncogene, 32, 3577-3586. https://doi.org/10.1038/onc.2012.381

Amin Al Olama, A., Kote-Jarai, Z., Schumacher, F. R., Wiklund, F., Berndt, S. I., Benlloch, S., Giles, G. G., Severi, G., Neal, D. E., Hamdy, F. C., Donovan, J. L., Hunter, D. J., Henderson, B. E., Thun, M. J., Gaziano, M., Giovannucci, E. L., Siddiq, A., Travis, R. C., Cox, D. G. ... The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology (2013). A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/dds425